文献速递胸部肿瘤

多灶性肺鳞状细胞癌的基因组分期不依赖于综合形态学评估

Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
PubMed 文献 · J Thorac Oncol · 2023-09-16

本研究对20对多灶性肺鳞状细胞癌(LSCC)肿瘤样本进行全外显子测序(WES),以WES为金标准判定肿瘤为独立原发肺癌(SPLC)或肺内转移(IPM),并与16位胸部病理学家的综合形态学评估比较。WES将11例归为SPLC、7例归为IPM,2例技术欠佳;形态学评估与WES的一致率为58.3%,病理学家间观察者一致性仅为中等(总体kappa=0.232)。结论认为基于形态学评估的多灶性LSCC分期不可靠,应采用综合基因组分析进行分期。

要点

  • WES将11例归为SPLC、7例归为IPM,2例技术欠佳。
  • 形态学评估与WES的一致率为58.3%。
  • 病理学家间形态学分期的总体kappa为0.232。

核心结论

  • 基于形态学评估的多灶性LSCC分期不可靠,应采用综合基因组分析进行分期。

研究设计与样本

  • 对20对多灶性LSCC肿瘤样本及匹配的正常淋巴结行全外显子测序(WES),使用Illumina NovaSeq6000 S4-Xp平台。
  • 将WES克隆与亚克隆分析数据与16位胸部病理学家的组织学评估进行比较。
  • 采用HTG EdgeSeq Precision Immuno-Oncology Panel对研究病例进行免疫基因谱分析。

主要发现

  • WES数据将11例归为SPLC、7例归为IPM,2例技术欠佳。
  • 分析显示显著的基因组和免疫原性异质性,但免疫基因表达谱与突变谱高度相关。
  • 归为IPM的肿瘤具有大量共享突变(范围为33.5%至80.7%)。
  • 每例的个体形态学评估与WES的一致率为58.3%。
  • 1例形态学一致判为IPM且与WES一致;另有17例中,每例形态学判读与WES一致的病理学家数从2位(1例)到15位(1例)不等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Morphologic and molecular data for staging of multifocal lung squamous cell carcinomas (LSCCs) are limited. In this study, whole exome sequencing (WES) was used as the gold standard to determine whether multifocal LSCC represented separate primary lung cancers (SPLCs) or intrapulmonary metastases (IPMs). Genomic profiles were compared with the comprehensive morphologic assessment. METHODS: WES was performed on 20 tumor pairs of multifocal LSCC and matched normal lymph nodes using the Illumina NovaSeq6000 S4-Xp (Illumina, San Diego, CA). WES clonal and subclonal analysis data were compared with histologic assessment by 16 thoracic pathologists. In addition, the immune gene profiling of the study cases was characterized by the HTG EdgeSeq Precision Immuno-Oncology Panel. RESULTS: By WES data, 11 cases were classified as SPLC and seven cases as IPM. Two cases were technically suboptimal. Analysis revealed marked genomic and immunogenic heterogeneity, but immune gene expression profiles highly correlated with mutation profiles. Tumors classified as IPM have a large number of shared mutations (ranging from 33.5% to 80.7%). The agreement between individual morphologic assessments for each case and WES was 58.3%. One case was unanimously interpreted morphologically as IPM and was in agreement with WES. In a further 17 cases, the number of pathologists whose morphologic interpretation was in agreement with WES ranged from two (one case) to 15 pathologists (one case) per case. Pathologists showed a fair interobserver agreement in the morphologic staging of multiple LSCCs, with an overall kappa of 0.232. CONCLUSIONS: Staging of multifocal LSCC based on morphologic assessment is unreliable. Comprehensive genomic analyses should be adopted for the staging of multifocal LSCC.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Dacic S, Cao X, Bota-Rabassedas N, et al. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment. J Thorac Oncol. 2023. PMID: 37717856. doi:10.1016/j.jtho.2023.09.275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。